![Andreas Jenne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Andreas Jenne is the founder of SciRhom GmbH, founded in 2016, serving as Managing Director since its founding.
Dr. Jenne currently works at Ventura Biomed Investors GmbH as Investment Director.
Former jobs include Chief Executive Officer at Evotec (München) GmbH from 2005 to 2009, Chief Executive Officer at RSP Systems A from 2018 to 2020, Chief Executive Officer at NEO New Oncology GmbH, and Member of Investment Committee at High-Tech Gründerfonds Management GmbH from 2017 to 2022.
Dr. Jenne earned a doctorate from Ludwig-Maximilians-Universität München in 1998.
Aktive Positionen von Andreas Jenne
| Unternehmen | Position | Beginn |
|---|---|---|
SciRhom GmbH
 SciRhom GmbH BiotechnologyHealth Technology Operates as a pioneering biotech enterprise specialized in developing therapeutic antibodies | Gründer | 01.01.2016 |
Ventura Biomed Investors GmbH
 Ventura Biomed Investors GmbH Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | - |
Ehemalige bekannte Positionen von Andreas Jenne
| Unternehmen | Position | Ende |
|---|---|---|
High-Tech Gründerfonds Management GmbH
 High-Tech Gründerfonds Management GmbH Investment ManagersFinance HTGF invests in companies located in Germany. The firm focuses on chemistry, digital tech, industrial tech and life sciences sectors. It participates in pre-seed and seed stage capital requirements with an investment size of EUR 0.8 - 30 million. It makes co-investments, follow-on financing and also acts as a lead investor. | Private Equity Investor | 30.09.2022 |
RSP Systems A/S
 RSP Systems A/S Medical SpecialtiesHealth Technology Provides non-invasive solutions for sugar and insulin blood level measurements | Vorstandsvorsitzender | 31.01.2020 |
NEO New Oncology GmbH
 NEO New Oncology GmbH Medical/Nursing ServicesHealth Services Designs and develops diagnostic platform | Vorstandsvorsitzender | - |
Evotec (München) GmbH
 Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Provides manufacturing and research support services for pharmaceutical and biotechnology companies | Vorstandsvorsitzender | - |
Ausbildung von Andreas Jenne
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
45
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance HTGF invests in companies located in Germany. The firm focuses on chemistry, digital tech, industrial tech and life sciences sectors. It participates in pre-seed and seed stage capital requirements with an investment size of EUR 0.8 - 30 million. It makes co-investments, follow-on financing and also acts as a lead investor. | Finance |
Evotec (München) GmbH
Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Provides manufacturing and research support services for pharmaceutical and biotechnology companies | Process Industries |
RSP Systems A/S
RSP Systems A/S Medical SpecialtiesHealth Technology Provides non-invasive solutions for sugar and insulin blood level measurements | Health Technology |
NEO New Oncology GmbH
NEO New Oncology GmbH Medical/Nursing ServicesHealth Services Designs and develops diagnostic platform | Health Services |
SciRhom GmbH
SciRhom GmbH BiotechnologyHealth Technology Operates as a pioneering biotech enterprise specialized in developing therapeutic antibodies | Health Technology |
Ventura Biomed Investors GmbH
Ventura Biomed Investors GmbH Investment ManagersFinance Functions as an alternative investment manager | Finance |
